Noa Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Noa Therapeutics's estimated annual revenue is currently $1.9M per year.
- Noa Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Noa Therapeutics has 12 Employees.
- Noa Therapeutics grew their employee count by 33% last year.
Noa Therapeutics's People
Name | Title | Email/Phone |
---|
Noa Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.2M | 27 | 29% | $5M | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $0.9M | 11 | -72% | $39.4M | N/A |
#4 | $1M | 13 | -84% | $23.8M | N/A |
#5 | $94.4M | 609 | 8% | N/A | N/A |
#6 | $3.4M | 22 | 10% | N/A | N/A |
#7 | $9.5M | 61 | -68% | N/A | N/A |
#8 | $18.1M | 117 | 30% | N/A | N/A |
#9 | $21.7M | 140 | -6% | N/A | N/A |
#10 | $1M | 13 | -41% | N/A | N/A |
What Is Noa Therapeutics?
Noa Therapeutics Inc. (Noa) is a preclinical Canadian biotech company aiming to defy the convention of traditional drug development to revolutionize treatment options for those living with complex inflammatory skin diseases. Leveraging intelligent design, Noa is pioneering the development of multimodal therapeutics; a singularly radical approach to address unmet needs and unlock opportunities within underserved and untapped markets. Targeting a first use case in atopic dermatitis, Noa’s non-steroidal small molecules aim to simultaneously addressing three constructive therapeutic targets. Through this multilateral approach, Noa strives to provide meaningful outcomes and establish a new, inclusive, standard for the first-line-treatment of inflammatory skin disease.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 12 | -56% | $16.9M |
#2 | $0.9M | 12 | 50% | N/A |
#3 | $1.5M | 12 | -25% | N/A |
#4 | $0.7M | 12 | N/A | N/A |
#5 | $1M | 12 | N/A | N/A |